Lipopeptide vaccines--yesterday, today, and tomorrow (Q34749774)

4 August 2017

1 reference

title

Lipopeptide vaccines--yesterday, today, and tomorrow (English)

1 reference

4 August 2017

Lbachir BenMohamed

1

1 reference

4 August 2017

Steven L Wechsler

series ordinal

2

1 reference

4 August 2017

Anthony B Nesburn

series ordinal

3

1 reference

4 August 2017

publication date

1 July 2002

1 reference

Lancet Infectious Diseases

4 August 2017

published in

1 reference

4 August 2017

volume

2

1 reference

4 August 2017

issue

7

1 reference

4 August 2017

page(s)

425-431

1 reference

Approaches to improve engineered vaccines for human immunodeficiency virus and other viruses that cause chronic infections

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900318-3

7 January 2021

Vaccine development for hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900318-3

7 January 2021

Can the immune response control HIV infection?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900318-3

7 January 2021

Multiepitopic B- and T-cell responses induced in humans by a human immunodeficiency virus type 1 lipopeptide vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900318-3

7 January 2021

Single-chain lipopeptide vaccines for the induction of virus-specific cytotoxic T cell responses in randomly selected populations

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900318-3

7 January 2021

Therapeutic periocular vaccination with a subunit vaccine induces higher levels of herpes simplex virus-specific tear secretory immunoglobulin A than systemic vaccination and provides protection against recurrent spontaneous ocular shedding of virus

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900318-3

7 January 2021

Lipopeptides induce cell-mediated anti-HIV immune responses in seronegative volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900318-3

7 January 2021

High immunogenicity in chimpanzees of peptides and lipopeptides derived from four new Plasmodium falciparum pre-erythrocytic molecules

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900318-3

7 January 2021

Lipopeptide immunization without adjuvant induces potent and long-lasting B, T helper, and cytotoxic T lymphocyte responses against a malaria liver stage antigen in mice and chimpanzees

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900318-3

7 January 2021

Endocytosis of an HIV-derived lipopeptide into human dendritic cells followed by class I-restricted CD8(+) T lymphocyte activation

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900318-3

7 January 2021

Intranasal administration of a synthetic lipopeptide without adjuvant induces systemic immune responses

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900318-3

7 January 2021

Long-lasting anti-viral cytotoxic T lymphocytes induced in vivo with chimeric-multirestricted lipopeptides

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900318-3

7 January 2021

Efficiency of peptides and lipopeptides for in vivo priming of virus-specific cytotoxic T cells

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900318-3

7 January 2021

Evaluation of a Lipopeptide Immunogen as a Therapeutic in HIV Type 1-Seropositive Individuals

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900318-3

7 January 2021

Lipopeptide particles as the immunologically active component of CTL inducing vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900318-3

7 January 2021

Development of a lipopeptide-based therapeutic vaccine to treat chronic HBV infection. I. Induction of a primary cytotoxic T lymphocyte response in humans

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900318-3

7 January 2021

Totally synthetic lipid-containing polyoxime peptide constructs are potent immunogens

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900318-3

7 January 2021

Peptides bound to proteosomes via hydrophobic feet become highly immunogenic without adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900318-3

7 January 2021

Adjuvants for human vaccines--current status, problems and future prospects

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900318-3

7 January 2021

Immunogenicity of recombinant influenza virus haemagglutinin carrying peptides from the envelope protein of human immunodeficiency virus type 1

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900318-3

7 January 2021

Attenuated mutants of the intracellular bacterium Listeria monocytogenes obtained by single amino acid substitutions in listeriolysin O

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900318-3

7 January 2021

Liposomes as carriers for vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900318-3

7 January 2021

Immunological adjuvants: a role for liposomes

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900318-3

7 January 2021

Antigenic presentation of small molecules and peptides conjugated to a preformed iscom as carrier

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900318-3

7 January 2021

Synthetic peptide vaccine design: synthesis and properties of a high-density multiple antigenic peptide system

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900318-3

7 January 2021

Immunogenicity of a synthetic HBsAg peptide: enhancement by conjugation to a fatty acid carrier

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900318-3

7 January 2021

Human T-lymphocyte response in vitro to synthetic peptides of herpes simplex virus glycoprotein D.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900318-3

7 January 2021

Antiviral cytotoxic T cell response induced by in vivo priming with a free synthetic peptide

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900318-3

7 January 2021

In vivo priming of virus-specific cytotoxic T lymphocytes with synthetic lipopeptide vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900318-3

7 January 2021

Fine specificity of cytotoxic T lymphocytes primed in vivo either with virus or synthetic lipopeptide vaccine or primed in vitro with peptide

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900318-3

7 January 2021

Influence of peptide acylation, liposome incorporation, and synthetic immunomodulators on the immunogenicity of a 1-23 peptide of glycoprotein D of herpes simplex virus: implications for subunit vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900318-3

7 January 2021

Comparative efficiency of simple lipopeptide constructs for in vivo induction of virus-specific CTL.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900318-3

7 January 2021

A totally synthetic polyoxime malaria vaccine containing Plasmodium falciparum B cell and universal T cell epitopes elicits immune responses in volunteers of diverse HLA types

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900318-3

7 January 2021

Extension of HLA-A*0201-restricted minimal epitope by N epsilon-palmitoyl-lysine increases the life span of functional presentation to cytotoxic T cells

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900318-3

7 January 2021

Effect of a lipopeptidic formulation on macrophage activation and peptide presentation to T cells

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900318-3

7 January 2021

Dendritic cells and the control of immunity

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900318-3

7 January 2021

Oral vaccination with immune stimulating complexes.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900318-3

7 January 2021

IFN-gamma-derived lipopeptides: influence of lipid modification on the conformation and the ability to induce MHC class II expression on murine and human cells

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900318-3

7 January 2021

Monopalmitic acid-peptide conjugates induce cytotoxic T cell responses against malarial epitopes: importance of spacer amino acids

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900318-3

7 January 2021

Mycoplasma fermentans lipoprotein M161Ag-induced cell activation is mediated by Toll-like receptor 2: role of N-terminal hydrophobic portion in its multiple functions

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900318-3

7 January 2021

Microbial lipopeptides stimulate dendritic cell maturation via Toll-like receptor 2.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900318-3

7 January 2021

Discrimination of bacterial lipoproteins by Toll-like receptor 6

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900318-3

7 January 2021

Evaluation of T-cell responses to peptides and lipopeptides with MHC class I binding motifs derived from the amino acid sequence of the 19-kDa lipoprotein of Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900318-3

7 January 2021

Protection against Plasmodium falciparum malaria in chimpanzees by immunization with the conserved pre-erythrocytic liver-stage antigen 3.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900318-3

7 January 2021

Induction of CTL responses and identification of a novel epitope of hepatitis B virus surface antigens in C57BL/6 mice immunized with recombinant vaccinia viruses

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900318-3

7 January 2021

Expression of hepatitis C virus proteins does not interfere with major histocompatibility complex class I processing and presentation in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900318-3

7 January 2021

Characterization of hepatitis C virus core-specific immune responses primed in rhesus macaques by a nonclassical ISCOM vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900318-3

7 January 2021

Pools of lipidated HTL-CTL constructs prime for multiple HBV and HCV CTL epitope responses

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900318-3

7 January 2021

Induction of CTL response by a minimal epitope vaccine in HLA A*0201/DR1 transgenic mice: dependence on HLA class II restricted T(H) response.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900318-3

7 January 2021

Immunobiology of dendritic cells in the respiratory tract: steady-state and inflammatory sentinels?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900318-3

7 January 2021

The dendritic cell system and its role in immunogenicity

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900318-3

7 January 2021

Freshly isolated Peyer's patch, but not spleen, dendritic cells produce interleukin 10 and induce the differentiation of T helper type 2 cells

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900318-3

7 January 2021

10.1016/S1473-3099(02)00318-3

Identifiers

DOI

1 reference

4 August 2017

1 reference